The new strain, also known as XBB.1.16, is presenting a few new issues that we haven't really seen with infections before.
It’s labeled by the World Health Organization as a “variant under monitoring,” according toAdvertisement
As of last week, it represented a little more than 7% of cases in the U.S. nationwide — though certain parts of the country are being hit with this variant harder than others. The symptoms of this new variant are also a little different from what we’ve seen in the past. How can you spot them and how can you protect yourself? Here’s what to know:Particularly in children, conjunctivitis — red, itchy eyes — has been a reported symptom, according to Binnicker.
“Depending on where you live, if you’re in the United States, if you’re in a place that’s starting to see the pollination come out, a lot of these symptoms are really similar to what you would see with spring allergies,” Guest said. “And so that does bring up the need to make sure you’re doing COVID tests if you have any of these symptoms.”Red, itchy eyes have been reported in children infected with XBB.1.16, but adults may experience the symptom as well.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Itchy Eyes? The New ‘Arcturus' COVID Variant, or XBB.1.16, Could Be Behind ItA new COVID variant being monitored by health officials and spreading in multiple countries is bringing with it a new symptom that could be confusing for some this time of year — itchy eyes.
Read more »
What to know about XBB.1.16, a new Omicron variant on the WHO's radarThere's a new variant of the coronavirus that infectious disease experts and public health officials are keeping a close eye on. XBB.1.16, also known as Arcturus, is an Omicron subvariant that appears to be more transmissible and has fueled a recent surge of COVID-19 cases in India. While the variant is circulating at low levels in the U.S., health officials are closely monitoring it.
Read more »
What to know about XBB.1.16, a new Omicron variant on the WHO’s radarA new coronavirus variant has caused a surge in COVID-19 cases in India, and doctors have flagged conjunctivitis as a possible symptom associated with it.
Read more »
FDA simplifies COVID vaccine schedules, withdraws authorization for older COVID-19 vaccines targeting virus' original strainThe FDA is authorizing a second omicron-targeted bivalent COVID-19 booster vaccine for people over 65 or who are immunocompromised, the agency announces.
Read more »
AstraZeneca confident new COVID antibody protects against known variantsAstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said.
Read more »
AstraZeneca Confident New COVID Antibody Protects Against Known VariantsAstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said.
Read more »